Back
Relay Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
52
RLAY
Relay Therapeutics
Last Price:
5.95
Seasonality Move:
2.51%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing selling pressure, which indicates risk of future bearish movement.
Relay Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6 | Buy |
| 20-day SMA: | 6.21 | Sell |
| 50-day SMA: | 6.78 | Sell |
| 200-day SMA: | 7.5 | Sell |
| 8-day EMA: | 6.09 | Buy |
| 20-day EMA: | 6.21 | Sell |
| 50-day EMA: | 6.59 | Sell |
| 200-day EMA: | 7.69 | Sell |
Relay Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 46.13 | Sell |
| Chaikin Money Flow: | -660811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.92 - 6.62) | Sell |
| Bollinger Bands (100): | (6.16 - 7.98) | Sell |
Relay Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 6.16 while RLAY 8-day simple moving average is 6.00, which is a Buy signal.
- The stock price of RLAY is 6.16 while Relay Therapeutics 20-day SMA is 6.21, which makes it a Sell.
- Relay Therapeutics 50-day simple moving average is 6.78 while RLAY share price is 6.16, making it a Sell technically.
- RLAY stock price is 6.16 and Relay Therapeutics 200-day simple moving average is 7.50, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Buy
52
Relay Therapeutics (RLAY)
is a Buy
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Buy
The current Relay Therapeutics [RLAY] share price is $6.16. The Score for RLAY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Relay Therapeutics Stock Info
Market Cap:
1.03B
Price in USD:
6.16
Share Volume:
1.13M
Relay Therapeutics 52-Week Range
52-Week High:
12.14
52-Week Low:
5.60
Buy
52
Relay Therapeutics (RLAY)
is a Buy
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 6.16 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is not overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 6.16 while RLAY 8-day exponential moving average is 6.09, which is a Buy signal.
- The stock price of RLAY is 6.16 while Relay Therapeutics 20-day EMA is 6.21, which makes it a Sell.
- Relay Therapeutics 50-day exponential moving average is 6.59 while RLAY share price is 6.16, making it a Sell technically.
- RLAY stock price is 6.16 and Relay Therapeutics 200-day simple moving average is 7.69, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Relay Therapeutics is a Sell
- Relay Therapeutics Relative Strength Index (RSI) is 46.13, which suggest Relay Therapeutics is oversold
- The Bollinger Bands (25) for Relay Therapeutics is (5.92 - 6.62), which suggest Relay Therapeutics is a Sell
- The Bollinger Bands (100) for Relay Therapeutics is (6.16 - 7.98), which suggest Relay Therapeutics is a Sell
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.